Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Debt to Equity (2019 - 2020)

Historic Debt to Equity for aTYR PHARMA (ATYR) over the last 2 years, with Q3 2020 value amounting to $0.1.

  • aTYR PHARMA's Debt to Equity fell 7596.2% to $0.1 in Q3 2020 from the same period last year, while for Sep 2020 it was $0.1, marking a year-over-year decrease of 7596.2%. This contributed to the annual value of $0.41 for FY2019, which is N/A changed from last year.
  • aTYR PHARMA's Debt to Equity amounted to $0.1 in Q3 2020, which was down 7596.2% from $0.14 recorded in Q2 2020.
  • In the past 5 years, aTYR PHARMA's Debt to Equity registered a high of $0.48 during Q1 2019, and its lowest value of $0.1 during Q3 2020.